Articles

Cellworks Omics Biology Model (CBM) to predict therapy response and identify biomarkers for all- trans retinoic acid (ATRA) benefit as addition to induction chemotherapy in adults with acute myeloid leukemia (AML)

Journal of Clinical Oncology, 2021
Cellworks Singula™ Accurately Predicts Clinical Outcome from Treatments in Patients with NSCLCPersonalized Therapy Biosimulation Using Multi-Omic Data Predicts OS and PFS for NSCLC Patients

BioSpace, 2021
Cellworks Singula™ Delivers Superior OS and DFS Predictions for Brain Cancer Patients in myCare-022-03 Clinical Trial

International Business Times, 2021
Study: Advanced multi-omics platform predicts superior OS and DFS for in glioblastoma

The Cancer Letter, 2021
Cellworks Singula(TM) Delivers Superior OS and DFS Predictions for Brain Cancer Patients in myCare-022-03 Clinical Trial

MarketWatch , 2021
Cellworks CBM Clinical Study Identifies Novel Biomarkers for ATRA Benefit and Failure in AML Patients

BioSpace, 2021
Moving Oncology Beyond
‘One Mutation, One Drug’

Clinical Omics, 2021
myCare Clinical Studies Show Cellworks Singula™ Achieves Superior Therapy Response Predictions for Brain Cancer Patients

Brain Tumor Research, 2020
myCare Clinical Studies Show Cellworks Singula™ Achieves Superior Therapy Response Predictions for Brain Cancer Patients

Chicago Daily Herald, 2020
myCare Clinical Studies Show Cellworks Singula™ Achieves Superior Therapy Response Predictions for Brain Cancer Patients

Boston Herald, 2020
myCare Clinical Studies Show Cellworks Singula™ Achieves Superior Therapy Response Predictions for Brain Cancer Patients

UK Biotech, 2020
Superior therapy response predictions for patients with acute myeloid leukemia (AML) using Cellworks Singula: MyCare-009-01

MDLinx, 2020
Superior therapy response predictions for patients with glioblastoma (GBM) using Cellworks Singula: MyCare-009-03.

Journal of Clinical Oncology, 2020
Superior therapy response predictions for patients with acute myeloid leukemia (AML) using Cellworks Singula: MyCare-009-01

Journal of Clinical Oncology, 2020
Superior therapy response predictions for patients with pancreatic cancer (PDAC) using Cellworks Singula: MyCare-009-05

Journal of Clinical Oncology, 2020
Superior therapy response predictions for patients with pancreatic cancer (PDAC) using Cellworks Singula: MyCare-009-05

Research Gate, 2020
Cellworks - Ideal Treatment Selection with a Computer Predictor

Silicon India, 2018
Cellworks AI - Driven Modeling System Can Help Predict Response to AML, MDS Therapies

GenomeWeb, 2018
Big Data And Virtualization In Precision Medicine

Businessworld, 2017
Combating Cancer Smartly

The Enterprise of Healthcare, 2017
Precision Medicine analytically combines therapies for individualized treatment results : Taher Abbasi

Healthworld, 2017
US-based Life Sciences Technology Company for Precision Medicine, Cellworks Focusing to Expand in India

Businessworld, 2017
Making Cancer Care Personal

University of Iowa, 2015
UF medical students use personalised medicine to catch cancer before it starts

University of Florida Health, 2015
To tailor cancer treatment: Study uses computer simulation to model patient cancer DNA

University of Florida Health, 2015

STAY INFORMED

Top